Therapeutic Effects of Semaglutide on Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus and Obesity: An Open-Label Controlled Trial. - Gad AI; Ibrahim NF; Almadani N; Mahfouz R; Nofal HA; El-Rafey DS; Ali HT; El-Hawary AT; Sadek AMEM (Diseases (Basel, Switzerland), 2024)